C
Carlo Brugnara
Researcher at Boston Children's Hospital
Publications - 348
Citations - 20837
Carlo Brugnara is an academic researcher from Boston Children's Hospital. The author has contributed to research in topics: Red blood cell & Iron deficiency. The author has an hindex of 76, co-authored 333 publications receiving 19351 citations. Previous affiliations of Carlo Brugnara include Albert Einstein College of Medicine & University of Kansas.
Papers
More filters
Journal ArticleDOI
An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports.
Nader Rifai,Thomas M. Annesley,Jens P. Berg,Carlo Brugnara,Edgard Delvin,Edmund J. Lamb,Paul M. Ness,Mario Plebani,Mark R. Wick,Alan H.B. Wu,Joris Delanghe +10 more
TL;DR: For commercial diagnostic tests, authors must include the actual name and generation of assay, the manufacturer, and the instrument used for analyses.
Journal ArticleDOI
Imatinib Protects Against Hypoxia/Reoxygenation Induced Lung and Kidney Injury in a Humanized Mouse Model for SCD
Alessandro Matte,Enrica Federti,Antonio Rechiutti,Amtonella Panataleo,Roberta Russo,Francesco Michelangelo Turrini,Angela Siciliano,Pierre-Louis Tharaux,Wassim El Nemer,Serge Cedrick,Anne Janin,Christophe Leboeuf,Wilson Babu,Achille Iolascon,Carlo Brugnara,Lucia De Franceschi +15 more
TL;DR: Data indicate that Imatinib acts on multiple targets, modulating signal transduction and reducing inflammatory vasculopathy and extracellular matrix remodeling process related to VOC in SCD.
Journal ArticleDOI
Full-disclosure in industry-sponsored laboratory medicine research studies: statement by the Consortium of Laboratory Medicine Journal Editors.
Nader Rifai,Mario Plebani,Alan H.B. Wu,Carlo Brugnara,Edgard Delvin,Edmund J. Lamb,Paul M. Ness,Mark R. Wick,Jens P. Berg +8 more
TL;DR: An editorial focusing on the first step toward full-disclosure in industrysponsored laboratory medicine studies, which is meant to complement the efforts of the World Association of Medical Editors (WAME) and the Committee on Publication Ethics (COPE) by issuing guidelines and requirements that are specifi c to laboratory medicine issues.
Journal ArticleDOI
The American Journal of Hematology, 2011 and beyond
Carlo Brugnara,Ayalew Tefferi +1 more
Patent
Triaryl methane compounds and their use in the treatment of diarrhea and scours
TL;DR: In this paper, a method and product for treating and preventing diarrhea and scours is provided, which involves treating a subject who has diarrhea, or scours, or is at risk of getting diarrhea, with an aromatic compound of the invention.